Genzyme Offers US$600 M for Bone Care

By Business Review Editor

Pharma Deals Review: Vol 2005 Issue 60 (Table of Contents)

Published: 5 Jun-2005

DOI: 10.3833/pdr.v2005.i60.673     ISSN: 1756-7874

Section: Mergers & Acquisitions

Fulltext:

Abstract

Genzyme launched a US$600 M cash bid for the increasingly profitable speciality pharmaceutical company Bone care International...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details